Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

20

Revenue 2017

Triumeq

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Triumeq was produced by GlaxoSmithKline.

CHMP backs first-line use for AZ’s Tagrisso in lung cancer

CHMP backs first-line use for AZ’s Tagrisso in lung cancer to Triumeq (abacavir/dolutegravir/lamivudine), currently spearheading a gain in HIV market share for Viiv. ... Gilead reported new data last month showing that it was possible to switch from Triumeq to Biktarvy with no loss of efficacy and - it claims -

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more the US, analysts say the drug combination is already gaining market share from GSK’s Triumeq and Tivicay.

Gilead says switching studies back new HIV therapy Biktarvy

Gilead says switching studies back new HIV therapy Biktarvy Patients who switched from rival Triumeq could maintain viral suppression over the trial period. ... Both Biktarvy and Triumeq are fixed-dose triple therapies for HIV delivered once-daily, and competition in the marketplace is expected to be fierce.

Gilead’s triple HIV drug approval prompts GSK lawsuit

Gilead’s triple HIV drug approval prompts GSK lawsuit which was first approved in the US in 2013 and is a key component of ViiV’s latest HIV product launches including three-drug combo Triumeq and recently-approved Juluca. ... forecasts. Tivicay and Triumeq posted strong growth to reach £1.4bn and

GSK’s ViiV gets US okay for two-drug HIV regimen

GSK’s ViiV gets US okay for two-drug HIV regimen ViiV has said Juluca will be priced at about $31, 000-a-year, comparable to its three-drug HIV regimen Triumeq (abacavir, lamivudine and dolutegravir), a $1.7bn product that is

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics